• Phenobarbital, Urine
  • BRCA1 and BRCA2 Gene Mutations Analysis (duplication/deletion and large gene rearrangements)
  • Apolipoprotein A-II (APOA2) Gene Analysis
  • Hepatitis B Surface Antibody, Qualitative
  • Protein C, Total Antigen
  • Urinary pH
  • Osmolality, Urine
  • CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism
Medical Test

Methodology
Access to Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Polymorphism is restricted.
Loading...